Comment on “Early Versus Later Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
Restricted accessLetterFirst published online 2026
Comment on “Early Versus Later Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
KowCSRamachandramDSThiruchelvamKHasanSSZaihanAF.Early versus later anticoagulation after ischemic stroke in atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Hosp Pharm. Published online 2026. doi:10.1177/00185787251415491
2.
HigginsJLópez-LópezJA.Reflections on the I-squared index for measuring inconsistency in meta-analysis. Res Synth Methods. Published online 2025. doi:10.1017/rsm.2025.10062
3.
YuZZhuW.Evaluation of early versus delayed DOACs initiation in acute ischemic stroke patients with AF. Clin Appl Thrombos-Hemostas. Published online 2025. doi:10.1177/10760296251375864
4.
IndrayanA.Research methodology and biostatistics series VIII – statistical relationship versus cause-effect relationship between medical factors. Med J. Published online 2025. doi:10.62830/mmj2-04-32c
5.
VerboutNGMaizaALetourneurA, et al. Abstract WP058: effects of protein C activator AB002 on hemorrhage and lesion volume in a rat model of collagenase-induced intracerebral hemorrhage. Stroke. Published online 2026. doi:10.1161/str.57.suppl_1.wp058
